Consultation News and Research

RSS

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China reported that its asthma drug Laevo-Bambutero will receive the China's State Food & Drug Administration's (SFDA) Fast Track Approval to enter clinical trials. The SFDA's Drug Review and Evaluation Center told the Company during recent consultations at the end of the Company's IND that formal approval would be granted by the Beijing office of the SFDA.

21 Apr 2010

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

A computerised diagnostic model outperforms clinical judgement for the diagnosis of fever in young children, and may improve early treatment, finds a study published on bmj.com today.

21 Apr 2010

Patients dismissed from hospital with noncardiac chest pain continue to experience cardiac events: Study

The growing number of Americans with cardiovascular disease has caused a heightened sensitivity in the evaluation of chest pain. In a study published in the April issue of Mayo Clinic Proceedings researchers reported that patients dismissed from the hospital with noncardiac chest pain continue to experience cardiac events, which may highlight a need for more aggressive cardiovascular risk factor management in this population.

21 Apr 2010

Updated clinical guidelines presented at EAU Anniversary Congress

A number of updated guidelines are presented at the Anniversary Congress of the European Association of Urology (EAU) held in Barcelona, from 16 through 20 April. The abridged versions - Pocket Guidelines - which are based on the extended text documents will also be available in Barcelona to all EAU members and press.

17 Apr 2010

AKI patients admitted to hospital on a weekend more likely to die: Study

Patients with acute kidney injury who are admitted to the hospital on a weekend are more likely to die than those admitted on a weekday, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. This disparity was most evident in smaller hospitals.

16 Apr 2010

New proposals to protect children and young people from tobacco-related harm

New proposals to protect children and young people from tobacco-related harm have been unveiled by the Welsh Assembly government.

16 Apr 2010

Embryos with two mums to remove the risk of hereditary diseases: new research

New research published in the journal Nature, could pave the way to world’s first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of “designer babies”.

16 Apr 2010

Albert Einstein College of Medicine of Yeshiva University receives funds to expand stem cell research capabilities

Albert Einstein College of Medicine of Yeshiva University has been awarded $10 million from the National Institutes of Health to expand its stem cell research capabilities. The funds will be used to create new laboratories in order to increase its already substantial base of stem cell investigators.

16 Apr 2010

Obama administration officials reflect on details, implementation of Global Health Initiative

Three senior Obama administration officials with global health-related portfolios spoke about the details and implementation of President Barack Obama's Global Health Initiative during a forum Wednesday at the Kaiser Family Foundation in Washington, D.C.

15 Apr 2010

Potential new drug for treatment of MS to be presented at AAN Annual Meeting

Researchers from Mount Sinai School of Medicine will present several studies at the American Academy of Neurology Annual Meeting, including a potential new drug for the treatment of multiple sclerosis and surprising trends showing a reduction in the disease's severity. The meeting will take place April 10-17 in Toronto.

15 Apr 2010

Opinions divided on swine flu fear

According to health experts the swine flu pandemic is far from over and remains a threat to the population, especially the young. John Mackenzie, the Australian who heads the World Health Organization’s independent but secretive Emergency Committee said in a statement on Wednesday, “This is just as severe as we saw in 1957 and 1968, with one major difference. We are not seeing deaths in the elderly but we are seeing them in a more important group of the population, healthy young adults… It is much more severe than people tend to talk about.”

15 Apr 2010

Second stage of pool laws will cost a precious buck to 70% pool owners

The Bligh Government yesterday released further changes in the pool safety laws and nearly 70% of all Gold Coast and Queensland homes with pools, including portable and inflatable ones will need to spend extra on upgrades.

14 Apr 2010

Lockheed Martin pledges $4M to aid UCLA Health System's Operation Mend program

The Lockheed Martin Corp. announced today a pledge of $4 million to benefit the UCLA Health System's Operation Mend program, which provides reconstructive surgeries and other health care needs to U.S. military personnel wounded in Iraq and Afghanistan.

13 Apr 2010

Hospira's proposed merger and loan agreements better than MPI's, says Javelin Pharmaceuticals

Javelin Pharmaceuticals, Inc. announced today that it had received a binding offer from Hospira, Inc. and its wholly-owned subsidiary, Discus Acquisition Corporation ("Discus"), to enter into a merger agreement, a loan and security agreement and intellectual property security agreements whereby Discus will, subject to certain conditions, commence an all cash tender offer to acquire all of the outstanding shares of Javelin at a per share price of $2.20.

12 Apr 2010

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

12 Apr 2010

Consultation News and Research

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

Patients dismissed from hospital with noncardiac chest pain continue to experience cardiac events: Study

Updated clinical guidelines presented at EAU Anniversary Congress

AKI patients admitted to hospital on a weekend more likely to die: Study

New proposals to protect children and young people from tobacco-related harm

Embryos with two mums to remove the risk of hereditary diseases: new research

Albert Einstein College of Medicine of Yeshiva University receives funds to expand stem cell research capabilities

Obama administration officials reflect on details, implementation of Global Health Initiative

Potential new drug for treatment of MS to be presented at AAN Annual Meeting

Opinions divided on swine flu fear

Second stage of pool laws will cost a precious buck to 70% pool owners

Lockheed Martin pledges $4M to aid UCLA Health System's Operation Mend program

Hospira's proposed merger and loan agreements better than MPI's, says Javelin Pharmaceuticals

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

Comprehensive cardiac health study provides superior results

Humana adopts radiology benefit management programs to reduce unnecessary radiation exposure

Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009

Kyto Biopharma enters agreement with Targeted Payload Therapeutics

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News